A detailed history of Dana Investment Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 168,216 shares of BMY stock, worth $9.72 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
168,216
Previous 149,261 12.7%
Holding current value
$9.72 Million
Previous $6.2 Million 40.45%
% of portfolio
0.29%
Previous 0.21%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $751,755 - $980,921
18,955 Added 12.7%
168,216 $8.71 Million
Q2 2024

Aug 27, 2024

SELL
$40.25 - $52.99 $5,594 - $7,365
-139 Reduced 0.09%
149,261 $6.2 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $7.31 Million - $9.63 Million
-181,682 Reduced 54.88%
149,400 $6.2 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $864,887 - $980,614
18,026 Added 5.76%
331,082 $18 Million
Q4 2023

Feb 07, 2024

BUY
$48.48 - $57.85 $4.52 Million - $5.39 Million
93,221 Added 42.4%
313,056 $16.1 Million
Q3 2023

Nov 15, 2023

SELL
$57.89 - $64.73 $8.51 Million - $9.51 Million
-146,978 Reduced 40.07%
219,835 $12.8 Million
Q2 2023

Aug 15, 2023

BUY
$63.71 - $70.74 $294,149 - $326,606
4,617 Added 1.27%
366,813 $23.5 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $912,580 - $1.04 Million
13,888 Added 3.99%
362,196 $25.1 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $1.62 Million - $1.91 Million
23,611 Added 7.27%
348,308 $25.1 Million
Q3 2022

Nov 15, 2022

BUY
$0.13 - $76.84 $29,177 - $17.2 Million
224,442 Added 223.87%
324,697 $23.1 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $7.28 Million - $8.02 Million
100,255 New
100,255 $7.72 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $19 Million - $22.3 Million
-321,184 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$61.91 - $67.42 $118,124 - $128,637
-1,908 Reduced 0.59%
321,184 $21.5 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $1.54 Million - $1.73 Million
25,897 Added 8.71%
323,092 $20.4 Million
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $98,331 - $111,427
-1,703 Reduced 0.57%
297,195 $18.4 Million
Q3 2020

Nov 10, 2020

SELL
$57.43 - $63.64 $4.35 Million - $4.82 Million
-75,741 Reduced 20.22%
298,898 $18 Million
Q2 2020

Aug 11, 2020

SELL
$54.82 - $64.09 $3.97 Million - $4.64 Million
-72,442 Reduced 16.2%
374,639 $22 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $2.91 Million - $4.23 Million
-62,726 Reduced 12.3%
447,081 $24.9 Million
Q4 2019

Feb 11, 2020

SELL
$49.21 - $64.19 $1.82 Million - $2.37 Million
-36,891 Reduced 6.75%
509,807 $32.7 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $2.12 Million - $2.51 Million
49,455 Added 9.95%
546,698 $27.7 Million
Q2 2019

Aug 13, 2019

SELL
$44.62 - $49.34 $1.34 Million - $1.48 Million
-29,982 Reduced 5.69%
497,243 $22.6 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $1.11 Million - $1.33 Million
24,711 Added 4.92%
527,225 $25.2 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $1.98 Million - $2.57 Million
-40,622 Reduced 7.48%
502,514 $26.1 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $30 Million - $33.8 Million
543,136 New
543,136 $33.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dana Investment Advisors, Inc. Portfolio

Follow Dana Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.